JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB85803

Anti-Interferon beta antibody

5

(1 리뷰)

|

(9 제품이 사용된 논문 )

Rabbit Polyclonal Interferon beta antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 9 publications.
2 이미지
Immunocytochemistry/ Immunofluorescence - Anti-Interferon beta antibody (AB85803)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Interferon beta antibody (AB85803)

ICC/IF image of ab85803 stained HepG2 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab85803, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899 Dylight 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Western blot - Anti-Interferon beta antibody (AB85803)
  • WB

Unknown

Western blot - Anti-Interferon beta antibody (AB85803)

The Interferon Beta protein sequence contains both a phosphorylation and a glycosylation site (Swissprot). Post-translation modifications could account for the migration of the band at a higher molecular weight than predicted.

All lanes:

Western blot - Anti-Interferon beta antibody (ab85803) at 1 µg/mL

Lane 1:

HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

Western blot - WI-38 whole cell lysate (<a href='/ko/products/cell-lysates/wi-38-whole-cell-lysate-ab3960'>ab3960</a>) at 10 µg

Lane 3:

Human liver tissue lysate - total protein (<a href='/ko/products/unavailable/human-liver-tissue-lysate-total-protein-ab29889'>ab29889</a>) at 10 µg

Lane 4:

Lung (Human) Tissue Lysate at 10 µg

Lane 5:

Human kidney tissue lysate - total protein (<a href='/ko/products/unavailable/human-kidney-tissue-lysate-total-protein-ab30203'>ab30203</a>) at 10 µg

Lane 6:

Human spleen tissue lysate - total protein (<a href='/ko/products/unavailable/human-spleen-tissue-lysate-total-protein-ab29699'>ab29699</a>) at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 22 kDa

Observed band size: 110 kDa,120 kDa,160 kDa,30 kDa,37 kDa

true

Exposure time: 20min

주요 정보

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

From Jan 2024, QC testing of replenishment batches of this polyclonal changed. All tested and expected application and reactive species combinations are still covered by our Abcam product promise. However, we no longer test all applications. For more information on a specific batch, please contact our Scientific Support who will be happy to help.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Macaque monkey": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Immunogen
보관 버퍼
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Interferon beta also known as IFN-beta or beta interferon is a type I interferon with a mass of approximately 20 kDa. It originates primarily from fibroblasts and plays an essential role in the immune response. This protein targets and binds to specific cell surface receptors initiating various antiviral states within cells. This action assists in slowing down viral replication and spread. IFN-beta's expression increases in response to viral infections making it an important component in the body's first line of defense against pathogens.
Biological function summary

Interferon beta functions as an important mediator of immune functions regulating the activity of natural killer cells and macrophages. It also boosts antigen presentation to T cells. Interferon beta belongs to the larger family of interferons which includes IFN-alpha and IFN-gamma each having distinct effects but working together to mount an effective immune response. Though it does not form part of a complex it plays a critical standalone role in immune signaling pathways.

Pathways

Interferon beta associates strongly with the JAK-STAT signaling pathway. Upon activation it interacts with receptors to phosphorylate STAT proteins mainly STAT1 and STAT2 which then dimerize and translocate to the nucleus to trigger gene expression. Another important pathway is the antiviral response where interferon beta modulates the expression of hundreds of interferon-stimulated genes. These pathways intricately involve other proteins like IFN-alpha and IFN-gamma which work synergistically to establish an effective antiviral environment.

Interferon beta shows significant implications in multiple sclerosis and hepatitis C infection. It is widely used as a therapeutic agent in managing multiple sclerosis by modulating the immune response to reduce inflammation and slow disease progression. Similarly its role in antiviral defense makes it relevant to hepatitis C infection management. In these contexts IFN-alpha and IFN-gamma are also important as they share similar antiviral and immunomodulatory functions that can complement IFN-beta's actions enhancing the treatment's efficacy.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Type I interferon cytokine that plays a key role in the innate immune response to infection, developing tumors and other inflammatory stimuli (PubMed : 10049744, PubMed : 10556041, PubMed : 6157094, PubMed : 6171735, PubMed : 7665574, PubMed : 8027027, PubMed : 8969169). Signals via binding to high-affinity (IFNAR2) and low-affinity (IFNAR1) heterodimeric receptor, activating the canonical Jak-STAT signaling pathway resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response, such as antiviral proteins, regulators of cell proliferation and differentiation, and immunoregulatory proteins (PubMed : 10049744, PubMed : 10556041, PubMed : 7665574, PubMed : 8027027, PubMed : 8969169). Signals mostly via binding to a IFNAR1-IFNAR2 heterodimeric receptor, but can also function with IFNAR1 alone and independently of Jak-STAT pathways (By similarity). Elicits a wide variety of responses, including antiviral and antibacterial activities, and can regulate the development of B-cells, myelopoiesis and lipopolysaccharide (LPS)-inducible production of tumor necrosis factor (By similarity). Plays a role in neuronal homeostasis by regulating dopamine turnover and protecting dopaminergic neurons : acts by promoting neuronal autophagy and alpha-synuclein clearance, thereby preventing dopaminergic neuron loss (By similarity). IFNB1 is more potent than interferon-alpha (IFN-alpha) in inducing the apoptotic and antiproliferative pathways required for control of tumor cell growth (By similarity).
See full target information IFNB1

대체 명칭 보기

IFB, IFNB, IFNB1, Interferon beta, IFN-beta, Fibroblast interferon

제품이 사용된 논문 (9)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Journal for immunotherapy of cancer 12: PubMed38749537

2024

Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Kevin Chih-Yang Huang,Shu-Fen Chiang,Hsin-Yu Chang,Wei-Ze Hong,Jhen-Yu Chen,Pei-Chih Lee,Ji-An Liang,Tao-Wei Ke,Shin-Lei Peng,An-Cheng Shiau,Tsung-Wei Chen,Pei-Chen Yang,William Tzu-Liang Chen,K S Clifford Chao

British journal of cancer 129:1852-1862 PubMed37838813

2023

Preoperative chemoradiotherapy induces multiple pathways related to anti-tumour immunity in rectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ioannis M Koukourakis,Erasmia Xanthopoulou,Theologos I Sgouras,Maria Kouroupi,Alexandra Giatromanolaki,Vassilios Kouloulias,Dina Tiniakos,Anna Zygogianni

Investigative ophthalmology & visual science 64:19 PubMed36692471

2023

Effect of TRPM8 Functional Loss on Corneal Epithelial Wound Healing in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Lili Ran,Jing Feng,Xia Qi,Ting Liu,Benxiang Qi,Kai Jiang,Zhenzhen Zhang,Yang Yu,Qingjun Zhou,Lixin Xie

Molecular medicine reports 25: PubMed35485288

2022

A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement.

Applications

Unspecified application

Species

Unspecified reactive species

Adriana G Quiroz-Reyes,Carlos A González-Villarreal,Herminia Martínez-Rodriguez,Salvador Said-Fernández,Mario César Salinas-Carmona,Alberto Y Limón-Flores,Adolfo Soto-Domínguez,Gerardo Padilla-Rivas,Roberto Montes De Oca-Luna,Jose F Islas,Elsa N Garza-Treviño

Frontiers in immunology 12:741502 PubMed34671355

2021

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.

Applications

Unspecified application

Species

Unspecified reactive species

Mai M Abdelmoaty,Pravin Yeapuri,Jatin Machhi,Katherine E Olson,Farah Shahjin,Vikas Kumar,You Zhou,Jingjing Liang,Kabita Pandey,Arpan Acharya,Siddappa N Byrareddy,R Lee Mosley,Howard E Gendelman

bioRxiv : the preprint server for biology : PubMed34268510

2021

Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions.

Applications

Unspecified application

Species

Unspecified reactive species

Mai Abdelmoaty,Pravin Yeapuri,Jatin Machhi,Katherine Olson,Farah Shahjin,You Zhou,Liang Jingjing,Kabita Pandey,Arpan Acharya,Siddappa Byrareddy,Lee Mosley,Howard Gendelman

Allergy, asthma & immunology research 12:994-1011 PubMed32935491

2020

Chloroquine Treatment Suppresses Mucosal Inflammation in a Mouse Model of Eosinophilic Chronic Rhinosinusitis.

Applications

Unspecified application

Species

Unspecified reactive species

Mi Ra Choi,Jun Xu,Seulgi Lee,Sun Hee Yeon,Soo Kyoung Park,Ki Sang Rha,Yong Min Kim

Theranostics 10:9032-9049 PubMed32802177

2020

Autophagic degradation of PML promotes susceptibility to HSV-1 by stress-induced corticosterone.

Applications

Unspecified application

Species

Unspecified reactive species

Wen Li,Zhuo Luo,Chang-Yu Yan,Xiao-Hua Wang,Zheng-Jie He,Shu-Hua Ouyang,Chang Yan,Li-Fang Liu,Qing-Qing Zhou,Han-Lu Mu,Hai-Biao Gong,Wen-Jun Duan,Lei Liang,Hiroshi Kurihara,Du Feng,Yi-Fang Li,Rong-Rong He

Scientific reports 8:10203 PubMed29976933

2018

Efficient production of human interferon beta in the white of eggs from ovalbumin gene-targeted hens.

Applications

Unspecified application

Species

Unspecified reactive species

Isao Oishi,Kyoko Yoshii,Daichi Miyahara,Takahiro Tagami
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com